NYU
Using Arima's technology, NYU researchers were able to identify a novel rearrangement in the PDL-1 gene in a pediatric brain tumor, which led to treatment with immunotherapy.
Micronoma, NYU Partner to Develop Microbial Biomarkers of Lung Cancer
Micronoma aims to commercialize the biomarkers as a test based on its OncobiotaLUNG microbiome-based liquid biopsy platform.
At AACR, the company highlighted new prospective and retrospective data that it believes helps set its platform apart from other available ctDNA technologies.
Merck, Moderna's Personalized Vaccine-Keytruda Combo Shines Across Biomarker Subgroups at AACR
Premium
Adding Moderna's vaccine to Merck's checkpoint inhibitor in the adjuvant treatment setting benefited melanoma patients, even across biomarker groups like TMB and PD-L1.
NYU Langone Perlmutter Cancer Center to Validate Biological Dynamics Pancreatic Cancer Test
The collaboration will test retrospective samples from more than 200 patients to validate Biological Dynamics' platform.
Jan 17, 2023